PRESS RELEASE published on 02/16/2023 at 15:57, 1 year 9 months ago Cryptology’s estimated NAV per share as of 02/15/2023 is €4.35
PRESS RELEASE published on 02/09/2023 at 17:30, 1 year 9 months ago Cryptology’s estimated NAV per share as of 02/08/2023 is €4.28
PRESS RELEASE published on 02/02/2023 at 15:30, 1 year 9 months ago Cryptology’s estimated NAV per share as of 01/02/2023 is €4.37
PRESS RELEASE published on 01/26/2023 at 19:25, 1 year 9 months ago Cryptology’s estimated NAV per share as of 25/01/2023 is €4.43
PRESS RELEASE published on 01/19/2023 at 16:00, 1 year 10 months ago Cryptology’s estimated NAV per share as of 18/01/2023 is €4.51
PRESS RELEASE published on 01/17/2023 at 10:00, 1 year 10 months ago Cryptology Asset Group p.l.c. (“Cryptology”) & Deutsche Digital Assets (“DDA”) - Joint Press Release
PRESS RELEASE published on 01/12/2023 at 16:00, 1 year 10 months ago Cryptology’s estimated NAV per share as of 11/01/2023 is €4.07
PRESS RELEASE published on 01/05/2023 at 15:22, 1 year 10 months ago Cryptology’s estimated NAV per share as of 04/01/2023 is €4.07
Published on 11/21/2024 at 13:00, 38 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 38 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 38 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 38 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 3 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 23 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 40 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 18 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 53 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
